Average Co-Inventor Count = 4.83
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d Ip, LLC (17 from 262 patents)
17 patents:
1. 12358931 - 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
2. 12172994 - Pyrimidine compound as JAK kinase inhibitor
3. 11814377 - Pyrimidine compound as JAK kinase inhibitor
4. 11780852 - Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
5. 11730720 - ALK5 inhibitors
6. 11673879 - Substituted pyrimidines and methods of use
7. 11590116 - Substituted pyridines and methods of use
8. 11420965 - Pyrimidine compound as JAK kinase inhibitor
9. 11110095 - Pyrimidine compounds as JAK kinase inhibitors
10. 10988470 - Pyrimidine compound as JAK kinase inhibitor
11. 10952996 - ALK5 inhibitors
12. 10947254 - Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
13. 10774080 - Pyrimidine compound as JAK kinase inhibitor
14. 10562894 - Pyrimidine compound as JAK kinase inhibitor
15. 10308646 - Pyrimidine compound as JAK kinase inhibitor